Torthaí cuardaigh - Iñaki Etxeberría

  • 1 - 17 toradh as 17 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Revisiting Interleukin-12 as a Cancer Immunotherapy Agent

    Revisiting Interleukin-12 as a Cancer Immunotherapy Agent de réir Pedro Berraondo, Iñaki Etxeberría, Mariano Ponz‐Sarvisé, Ignacio Melero

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis

    New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis de réir Iñaki Etxeberría, Javier Glez‐Vaz, Álvaro Teijeira, Ignacio Melero

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy

    Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy de réir Alfonso R. Sánchez-Paulete, Sara Labiano, María E. Rodríguez-Ruiz, Arantza Azpilikueta, Iñaki Etxeberría, Elixabet Bolaños, Valérie Lang, Manuel Rodrı́guez, M. Ángela Aznar, Maria Jure‐Kunkel, Ignacio Melero

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Cytokines in clinical cancer immunotherapy

    Cytokines in clinical cancer immunotherapy de réir Pedro Berraondo, Miguel F. Sanmamed, María C. Ochoa, Iñaki Etxeberría, M. Ángela Aznar, Jose Luis Pérez‐Gracia, María E. Rodríguez-Ruiz, Mariano Ponz‐Sarvisé, Eduardo Castañón, Ignacio Melero

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation

    Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation de réir Álvaro Teijeira, Sara Labiano, Saray Garasa, Iñaki Etxeberría, Eva Santamaría, Ana Rouzaut, Michel Enamorado, Arantza Azpilikueta, Susana Inogès, Elixabet Bolaños, M. Ángela Aznar, Alfonso R. Sánchez-Paulete, David Sancho, Ignacio Melero

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Repurposing the yellow fever vaccine for intratumoral immunotherapy

    Repurposing the yellow fever vaccine for intratumoral immunotherapy de réir M. Ángela Aznar, Carmen Molina, Álvaro Teijeira, Inmaculada Rodríguez, Arantza Azpilikueta, Saray Garasa, Alfonso R. Sánchez-Paulete, Luna Cordeiro, Iñaki Etxeberría, Maite Álvarez, Sergio Rius‐Rocabert, Estanislao Nistal‐Villán, Pedro Berraondo, Ignacio Melero

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies

    TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies de réir María E. Rodríguez-Ruiz, Inmaculada Rodríguez, Lina Mayorga, Tania Labiano, Benigno Barbés, Iñaki Etxeberría, Mariano Ponz‐Sarvisé, Arantza Azpilikueta, Elixabet Bolaños, Miguel F. Sanmamed, Pedro Berraondo, Felipe A. Calvo, Mary Helen Barcellos‐Hoff, Jose Luis Pérez‐Gracia, Ignacio Melero

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming

    Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming de réir Alfonso R. Sánchez-Paulete, Álvaro Teijeira, José I. Quetglas, María E. Rodríguez-Ruiz, Álvaro Sánchez-Arráez, Sara Labiano, Iñaki Etxeberría, Arantza Azpilikueta, Elixabet Bolaños, María Cristina Ballesteros-Briones, Noëlia Casares, Sergio A. Quezada, Pedro Berraondo, David Sancho, Cristian Smerdou, Ignacio Melero

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Immunotherapeutic effects of intratumoral nanoplexed poly I:C

    Immunotherapeutic effects of intratumoral nanoplexed poly I:C de réir M. Ángela Aznar, Lourdes Planelles, Mercedes Pérez‐Olivares, Carmen Molina, Saray Garasa, Iñaki Etxeberría, Guiomar Pérez, Inmaculada Rodríguez, Elixabet Bolaños, Pedro P. López‐Casas, María E. Rodríguez-Ruiz, Jose Luis Pérez‐Gracia, Iván Márquez‐Rodas, Álvaro Teijeira, Marisol Quintero, Ignacio Melero

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy

    mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy de réir Irene Olivera, Elixabet Bolaños, José González-Gomariz, Sandra Hervás‐Stubbs, Karina V. Mariño, Carlos Luri‐Rey, Iñaki Etxeberría, Assunta Cirella, Josune Egea, Javier Glez‐Vaz, Saray Garasa, Maite Álvarez, Iñaki Eguren‐Santamaría, Sònia Guedan, Miguel F. Sanmamed, Pedro Berraondo, Gabriel A. Rabinovich, Álvaro Teijeira, Ignacio Melero

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β

    A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β de réir Irene Olivera, Rebeca Sanz‐Pamplona, Elixabet Bolaños, Inmaculada Rodríguez, Iñaki Etxeberría, Assunta Cirella, Josune Egea, Saray Garasa, Itziar Miguéliz, Iñaki Eguren‐Santamaría, Miguel F. Sanmamed, Javier Glez‐Vaz, Arantza Azpilikueta, Maite Álvarez, María C. Ochoa, Beatrice Malacrida, David Propper, Carlos E. de Andrea, Pedro Berraondo, Frances R. Balkwill, Álvaro Teijeira, Ignacio Melero

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

    Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA de réir Smita S. Chandran, Jiaqi Ma, Martin G. Klatt, Friederike Dündar, Chaitanya Bandlamudi, Pedram Razavi, Hannah Y. Wen, Britta Weigelt, Paul Zumbo, Si Ning Fu, Lauren B. Banks, Fei Yi, Enric Vercher, Iñaki Etxeberría, Watchain D. Bestman, Arnaud Da Cruz Paula, Ilinca Aricescu, Alexander Drilon, Doron Betel, David A. Scheinberg, Brian M. Baker, Christopher A. Klebanoff

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells

    Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells de réir Iñaki Etxeberría, Elixabet Bolaños, José I. Quetglas, Alena Gros, Alberto Villanueva, Jara Palomero, Alfonso R. Sánchez-Paulete, Josep M. Piulats, Xavier Matías‐Guiu, Irene Olivera, María C. Ochoa, Sara Labiano, Saray Garasa, Inmaculada Rodríguez, August Vidal, Uxua Mancheño, Sandra Hervás‐Stubbs, Arantza Azpilikueta, Itziar Otano, M. Ángela Aznar, Miguel F. Sanmamed, Susana Inogès, Pedro Berraondo, Álvaro Teijeira, Ignacio Melero

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation

    CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation de réir Itziar Otano, Arantza Azpilikueta, Javier Glez‐Vaz, Maite Álvarez, José Medina‐Echeverz, Iván Cortés‐Domínguez, Carlos Ortíz-de-Solórzano, Peter Ellmark, Sara Fritzell, Gabriela Hernández‐Hoyos, Michelle H. Nelson, María C. Ochoa, Elixabet Bolaños, Doina Cuculescu, Patricia Jáuregui, Sandra Sánchez‐Gregorio, Iñaki Etxeberría, María E. Rodríguez-Ruiz, Miguel F. Sanmamed, Álvaro Teijeira, Pedro Berraondo, Ignacio Melero

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

    CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity de réir Álvaro Teijeira, Saray Garasa, María Gato, Carlos Alfaro, Itziar Miguéliz, Assunta Cirella, Carlos de Andrea, María C. Ochoa, Itziar Otano, Iñaki Etxeberría, Maria Pilar Andueza, Celia Nieto, L. Resano, Arantza Azpilikueta, Marcello Allegretti, Maria De Pizzol, Mariano Ponz‐Sarvisé, Ana Rouzaut, Miguel F. Sanmamed, Kurt A. Schalper, Michael Carleton, Mario Mellado, María E. Rodríguez-Ruiz, Pedro Berraondo, Jose Luis Pérez‐Gracia, Ignacio Melero

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Tumour-wide RNA splicing aberrations generate actionable public neoantigens

    Tumour-wide RNA splicing aberrations generate actionable public neoantigens de réir Darwin Kwok, Nicholas Stevers, Iñaki Etxeberría, Takahide Nejo, Maggie Colton Cove, Lee H. Chen, Jangham Jung, Kaori Okada, Senthilnath Lakshmanachetty, Marco Gallus, Abhilash Barpanda, Chibo Hong, Gary K.L. Chan, Jerry Liu, Samuel H. Wu, Emilio Ramos, Akane Yamamichi, Payal Watchmaker, Hirokazu Ogino, Atsuro Saijo, Aidan Du, Nadia Grishanina, James Woo, Aarón Díaz, Shawn L. Hervey‐Jumper, Susan M. Chang, Joanna J. Phillips, Arun P. Wiita, Christopher A. Klebanoff, J Costello, Hideho Okada

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias

    Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias de réir Won Jun Kim, Edie I. Crosse, Emma De Neef, Iñaki Etxeberría, Erich Sabio, Eric Wang, Jan Philipp Bewersdorf, Kuan‐Ting Lin, Sydney X. Lu, Andrea E. Belleville, Nina Fox, Cynthia Castro, Pu Zhang, Takeshi Fujino, Jennifer Lewis, Jahan Rahman, Beatrice Zhang, Jeffrey D. Winick, Alexander M. Lewis, Robert F. Stanley, Susan DeWolf, Brigita Meškauskaitė Urben, Meril Takizawa, Tobias Krause, Henrik Molina, Ronan Chaligné, Priya Koppikar, Jeffrey J. Molldrem, Mathieu Gigoux, Taha Merghoub, Anthony F. Daniyan, Smita S. Chandran, Benjamin D. Greenbaum, Christopher A. Klebanoff, Robert K. Bradley, Omar Abdel‐Wahab

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: